Unicycive Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UNCY and other ETFs, options, and stocks.

About UNCY

Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The firm investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. 

CEO
Shalabh Gupta
CEOShalabh Gupta
Employees
21
Employees21
Headquarters
Los Altos, California
HeadquartersLos Altos, California
Founded
2016
Founded2016
Employees
21
Employees21

UNCY Key Statistics

Market cap
192.06M
Market cap192.06M
Price-Earnings ratio
-3.57
Price-Earnings ratio-3.57
Dividend yield
Dividend yield
Average volume
504.95K
Average volume504.95K
High today
$7.78
High today$7.78
Low today
$7.16
Low today$7.16
Open price
$7.28
Open price$7.28
Volume
534.47K
Volume534.47K
52 Week high
$11.00
52 Week high$11.00
52 Week low
$3.71
52 Week low$3.71

Stock Snapshot

With a market cap of 192.06M, Unicycive Therapeutics(UNCY) trades at $7.61. The stock has a price-to-earnings ratio of -3.57.

On 2026-04-22, Unicycive Therapeutics(UNCY) stock moved within a range of $7.16 to $7.78. With shares now at $7.61, the stock is trading +6.3% above its intraday low and -2.2% below the session's peak.

Trading volume for Unicycive Therapeutics(UNCY) stock has reached 534.47K, versus its average volume of 504.95K.

The stock's 52-week range extends from a low of $3.71 to a high of $11.00.

The stock's 52-week range extends from a low of $3.71 to a high of $11.00.

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own UNCY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.